South Korea: Record Highs, Record Concentration

Asia Ex-Japan Fund analysis

February 26th 2026

Executive Summary

Is South Korea back in favour? The data suggests a decisive shift. After a prolonged period of underweight positioning, Asia ex-Japan managers have moved South Korea to the largest country overweight in the region. It is now the second-largest allocation overall and sits at record levels of aggregate exposure.

What is driving the move? The answer is clear: Samsung Electronics and SK Hynix. The two stocks account for 63.4% of total South Korea exposure — a record concentration — and are held at a combined +2.8% overweight versus the index. By contrast, the rest of the country remains underweight on average.

So is this a country story or a stock story? The evidence points to the latter. South Korea’s return to overweight status is real, but it is narrowly led. This is a two-stock phenomenon rather than a broad-based reappraisal of the market.

Click above for the full South Korea Market Intelligence report, featuring detailed fund-level breakdowns of country, sector and stock exposure, plus time-series trends and positioning gap analysis.

Country Positioning
The charts below show current ownership dynamics at the country level for Asia ex-Japan active equity funds.  Chart 1 shows the average country weight across managers. South Korea is now the second-largest allocation in the region at 19.37%, marginally ahead of Taiwan (19.32%) and India (12.60%), but still well behind China & HK (35.22%). Together, these four markets dominate active allocations in Asia ex-Japan.

Relative to the benchmark, South Korea is starting to see clear support. It is currently the largest country overweight at +1.42% versus the index (Chart 4), with 64.1% of funds positioned overweight (Chart 5).  This contrasts sharply with Taiwan, where 86% of funds are underweight, at an average of -4.7% versus the benchmark.

Asia Big Four – Long-Term Dynamics

Regular readers will know this has not always been the case. The time-series charts below show South Korea’s rise through 2025.  Exhibit 1 shows South Korea overtaking both India and Taiwan to become the second-largest allocation in just 12 months. Over the same period, Asia ex-Japan funds moved from a net underweight to a clear overweight position (Exhibit 3), alongside a marked increase in the percentage of funds positioned overweight (Exhibit 2).

This was a deliberate active reallocation in favour of South Korea.

Fund-Level Positioning
Chart 31 shows the distribution of fund weights in South Korea. The bulk of allocations sit between 16% and 22%, with a broadly normal distribution and a smaller tail extending to more bullish positions above 30%.

Chart 32 shows that 60% of funds hold weights between the lower and upper quintiles of 16.1% and 22.4%. Importantly, overweight positions are clustered just above the 18% benchmark weight rather than skewed aggressively higher. Only a smaller cohort of funds sits at the top end of the range.

Stock-Level Positioning
Chart 100 breaks down South Korean ownership at the stock level. On an average weight basis, Samsung Electronics and SK Hynix dominate allocations. Combined, they account for 12.44% of average fund weight and 63.4% of total South Korea exposure (including Samsung ordinary and preferred shares).

Beyond these two names — which are also the largest overweight positions — ownership falls away sharply. A distinct second tier has emerged, with 25–32% of funds holding positions in stocks such as Naver Corp, Kia Corp and KB Financial.  A further 15 companies are owned by more than 10% of funds

South Korea’s Concentration Risks
The charts below highlight the growing reliance on Samsung Electronics and SK Hynix within total South Korea exposure. Much of the recent increase in country weight has been driven by these two companies, while the “Rest of South Korea” (shown in green) has only recovered marginally from the lows in late 2024 (Exhibit 5).

The top two stocks now account for 63.4% of total South Korea exposure — a record high, although comparable to the concentration seen in early 2024 (Exhibit 6).  Positioning versus the AC Asia ex-Japan index is even more revealing. Managers hold the top two stocks at an average +2.8% overweight, while the remainder of the country is, on average, -1.12% underweight (Exhibit 7).

We should not interpret South Korea’s new overweight status as a broad-based shift in country conviction. This is a two-stock phenomenon.

Stock to Watch
We highlight 14 stocks that stand out in our analysis.  Chart 120 shows the long-term percentage of funds invested in stocks seeing the largest short-term increases in ownership. SK Hynix is at new highs, while Samsung Electronics is moving back towards prior peak ownership levels. Samsung Electro-Mechanics, meanwhile, has seen a notable uptick from a much lower base.

Chart 121 highlights the largest declines in ownership. Naver Corp has clearly lost momentum in recent months. Hyundai Engineering & Construction and Kolmar Korea have also failed to gain traction among managers.

South Korea’s “rising stars” are shown in Chart 122. These are stocks at record ownership levels but still held by only 5–20% of managers — meaning they are not yet fully established positions. Hanwha Aerospace and Samsung Biologics lead this group, both showing significant increases in fund ownership over the past 12 months.

Finally, Chart 123 identifies South Korea’s “fallen angels” — stocks that were once core holdings but have seen sustained declines in ownership over the past decade. LG Chem and Hyundai Mobis stand out here, now largely absent from Asia ex-Japan active portfolios.

Terms and Conditions

Investor Positioning Report — Copley Fund Research Ltd  ·  Last updated: July 2026  ·  Registered in England and Wales

1. Who we are

Copley Fund Research Ltd provides proprietary institutional fund intelligence to listed companies and investor relations professionals. These terms govern every purchase of an Investor Positioning Report. By completing a purchase you confirm you have read, understood, and agreed to these terms in full.

2. What you are purchasing

The Investor Positioning Report is a bespoke PDF report mapping the institutional fund universe around your stock. It covers current investors, past investors, competitor investors, and white space investors. Every report is built from scratch for the specific company ordered and is not a standardised or templated product.

3. Delivery and process

Following payment or invoice issuance, Copley Fund Research will contact you within one working day to agree your competitor set. Production begins once the competitor set is confirmed in writing. The completed report will be released to you within 48 hours of production starting, provided payment has been received in full; where payment is outstanding, the report will be withheld until payment clears. If the requested company falls outside our covered fund universes, or a competitor set cannot be agreed, Copley Fund Research will issue a full refund or cancel the outstanding invoice.

4. Competitor set agreement

The competitor set is agreed with you in writing prior to production, and the report is built to that agreed specification. Requests to amend the competitor set after delivery, based on a change of preference rather than an error, may be treated as a new order.

5. Refund policy

Because each report is produced individually for your company, orders are non-refundable once production has begun, except as set out in clauses 3 and 5a below. By purchasing, you agree not to dispute the charge with your card provider on the basis that the service was not as described, provided the report has been delivered to the agreed specification or corrected under clause 5a.

5a. Quality remedy

If a delivered report contains a material error caused by Copley Fund Research — for example, an incorrect company analysed, a competitor omitted from the agreed set, or content missing from the specification in clause 2 — Copley Fund Research will correct and redeliver the report at no additional charge, within a reasonable timeframe. This is your sole remedy for such errors.

6. Data and accuracy

All fund positioning data in the report reflects holdings as disclosed at the most recently available reporting date at the time of compilation. The timing of fund holdings disclosures is determined by regulatory requirements applicable to each fund and is outside the control of Copley Fund Research Ltd. This data may not reflect current fund positions. Copley Fund Research takes reasonable care to ensure accuracy but makes no warranty, express or implied, as to the completeness or current accuracy of the underlying data — though this does not affect the quality remedy in clause 5a for errors in how that data was analysed or presented. Past fund positioning is not indicative of future fund behaviour or investment decisions.

7. Not investment advice

The Investor Positioning Report is produced for investor relations intelligence purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy, hold, or sell any security. The data reflects historical fund positioning and must not be relied upon as a prediction of future fund behaviour or investment decisions. Copley Fund Research Ltd is not authorised or regulated by the Financial Conduct Authority for the provision of investment advice.

8. Permitted use and confidentiality

The report is licensed for internal use by the purchasing organisation only. You may share it with employees and directors of your organisation. You may not: reproduce, redistribute, publish, or resell the report or any part of it; share it with any third party outside your organisation without prior written consent; use the fund or portfolio manager names contained in the report to approach those individuals on behalf of Copley Fund Research or in a manner that could damage Copley Fund Research's relationships with those funds; or use the data for any purpose other than your own investor relations strategy. The data, analysis, and methodology contained in the report are the intellectual property of Copley